Severe Cytokine Release Syndrome and Hemophagocytic Lymphohistiocytosis (HLH)-Like Syndrome Following Administration of Combined Brentuximab Vedotin and Nivolumab for Recurrent Classical Hodgkin Lymphoma: A Case Report
Journal of Blood Medicine · 2024-01 · Volume 15 · 29-34
DOI: 10.2147/jbm.s444004 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Blood Medicine, 2024-01. Verfasst von Osama Mosalem und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL, USA. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL, USA.
- Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Jacksonville, FL, USA.
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, FL, USA.
ORCID-Profile: Osama Mosalem, Tanmayi Pai, Muhamad Alhaj Moustafa
Zitieren
APA
Mosalem, O., Pai, T., Alqawasma, M., Shaikh, M., Li, K. D., & Alhaj Moustafa, M. (2024). Severe Cytokine Release Syndrome and Hemophagocytic Lymphohistiocytosis (HLH)-Like Syndrome Following Administration of Combined Brentuximab Vedotin and Nivolumab for Recurrent Classical Hodgkin Lymphoma: A Case Report. Journal of Blood Medicine, Volume 15, 29-34. https://doi.org/10.2147/jbm.s444004
Vancouver
Mosalem O, Pai T, Alqawasma M, Shaikh M, Li KD, Alhaj Moustafa M. Severe Cytokine Release Syndrome and Hemophagocytic Lymphohistiocytosis (HLH)-Like Syndrome Following Administration of Combined Brentuximab Vedotin and Nivolumab for Recurrent Classical Hodgkin Lymphoma: A Case Report. Journal of Blood Medicine. 2024;Volume 15:29-34. doi:10.2147/jbm.s444004
BibTeX
@article{Mosalem2024,
author = {Mosalem, Osama and Pai, Tanmayi and Alqawasma, Mohammed and Shaikh, Marwan and Li, K David and Alhaj Moustafa, Muhamad},
title = {Severe Cytokine Release Syndrome and Hemophagocytic Lymphohistiocytosis (HLH)-Like Syndrome Following Administration of Combined Brentuximab Vedotin and Nivolumab for Recurrent Classical Hodgkin Lymphoma: A Case Report},
journal = {Journal of Blood Medicine},
year = {2024},
volume = {Volume 15},
pages = {29--34},
doi = {10.2147/jbm.s444004}
}
EUVIMED